Gerber Kawasaki Wealth & Investment Management
Position in OCGN — Ocugen, Inc.
CIK 1666736
SANTA MONICA, CA
Position in OCGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$125,519
+$58,446 QoQ
Shares Held
69,348
+0.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Gerber Kawasaki Wealth & Investment Management holds $1,098,801 across 2 Biotechnology names. OCGN ranks #2 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
20,460 | $973,282 | |
| 2 | OCGN |
Ocugen, Inc.
This page
|
69,348 | $125,519 |
All Filings in OCGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $125,519 | 69,348 | Shares | Sole | 2026-05-07 | |
| 2025-06-30 | $67,073 | 69,148 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $55,664 | 69,148 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||